We are live on ! Find out more
LAB icon

Standard BioTools
LAB

119 hedge funds and large institutions have $387M invested in Standard BioTools in 2021 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 32 increasing their positions, 39 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

202% more call options, than puts

Call options by funds: $4.08M | Put options by funds: $1.35M

58% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 12

9% more capital invested

Capital invested by funds: $354M → $387M (+$32.4M)

5% more funds holding

Funds holding: 113 → 119 (+6)

0.16% more ownership

Funds ownership: 76.82% → 76.98% (+0.16%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

18% less repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 39

Holders
119
Holders Change
+6
Holders Change %
+5.31%
% of All Funds
2.08%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
19
Increased
32
Reduced
39
Closed
12
Calls
$4.08M
Puts
$1.35M
Net Calls
+$2.73M
Net Calls Change
+$2.2M

Top Buyers

1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$2.63M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$2.1M
3
N
Nuveen
North Carolina
+$1.92M
4
SAM
Silverback Asset Management
North Carolina
+$1.88M
5
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
+$1.53M

Top Sellers

1
Millennium Management
Millennium Management
New York
-$3.49M
2
CS
Candriam SCA
Luxembourg
-$1.07M
3
HSA
Hussman Strategic Advisors
Maryland
-$887K
4
Jennison Associates
Jennison Associates
New York
-$830K
5
CAM
Connacht Asset Management
New York
-$794K
Name Holding Trade Value Shares
Change 		Change in
Stake
ICM
1
Indaba Capital Management
California
$49.1M – – –
BlackRock
2
BlackRock
New York
$41.9M -$86.9K -13,207 -0.2%
Primecap Management
3
Primecap Management
California
$34.7M -$520K -79,110 -1%
O
4
OrbiMed
New York
$30.3M -$410K -62,300 -1%
Neuberger Berman Group
5
Neuberger Berman Group
New York
$27.7M -$416K -63,307 -1%
Vanguard Group
6
Vanguard Group
Pennsylvania
$23.6M -$506K -76,966 -2%
NIM
7
Needham Investment Management
New York
$21.7M +$262K +39,750 +1%
Millennium Management
8
Millennium Management
New York
$18.8M -$3.49M -530,143 -16%
BFM
9
Boothbay Fund Management
New York
$15.2M – – –
N
10
Nuveen
North Carolina
$13.4M +$1.92M +292,032 +18%
State Street
11
State Street
Massachusetts
$9.57M +$37.4K +5,690 +0.4%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$8.89M +$249K +37,887 +3%
TM
13
Tikvah Management
North Carolina
$8.24M – – –
PHS
14
PFM Health Sciences
California
$6.46M – – –
Dimensional Fund Advisors
15
Dimensional Fund Advisors
Texas
$6.27M +$1.31M +199,572 +27%
PCMI
16
Paradigm Capital Management Inc
New York
$6.04M – – –
D.E. Shaw & Co
17
D.E. Shaw & Co
New York
$5.2M +$516K +78,477 +11%
UBS Group
18
UBS Group
Switzerland
$5.19M -$45.8K -6,969 -0.9%
Northern Trust
19
Northern Trust
Illinois
$4.99M -$125K -18,927 -2%
PCM
20
Perkins Capital Management
Minnesota
$3.43M – – –
Adage Capital Partners
21
Adage Capital Partners
Massachusetts
$2.64M +$2.63M +400,000 New
Goldman Sachs
22
Goldman Sachs
New York
$2.49M +$499K +75,882 +25%
Balyasny Asset Management
23
Balyasny Asset Management
Illinois
$2.1M +$2.1M +318,991 New
Morgan Stanley
24
Morgan Stanley
New York
$1.91M +$463K +70,376 +32%
SAM
25
Silverback Asset Management
North Carolina
$1.88M +$1.88M +285,744 New
1
2 3 4 5

LAB Hedge Fund Activity: Q3 2021 in Review

119 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q3 2021, worth a combined $387M — up 9.1% from $354M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new LAB positions and 12 closed out — a net gain of 7 holders — while 32 added to existing stakes and 39 trimmed.

The largest buyer was Adage Capital Partners, opening a new position worth an estimated $2.63M. The largest seller was Millennium Management, cutting an estimated $3.49M.

  • 119 institutional investors held Standard BioTools (LAB) as of Q3 2021, up from 113 in Q2 2021.
  • Funds reported $387M of Standard BioTools stock for Q3 2021, up 9.1% quarter-over-quarter.
  • 19 funds opened new Standard BioTools positions in Q3 2021 and 12 closed out, a net change of +7 holders.
  • The largest Standard BioTools buyer in Q3 2021 was Adage Capital Partners, an estimated $2.63M added.
  • The largest Standard BioTools seller in Q3 2021 was Millennium Management, an estimated $3.49M sold.

Based on aggregated 13F filings for Q3 2021.